Search

Search Results
Results 19181 - 19190 of 19770 for Able-bodied
  • Trelegy Ellipta
    Drug - 22 Oct 2024
    Consumer Medicine Information (CMI) about Trelegy Ellipta intended for persons living in Australia.
  • Uncovering protein aggregation mechanisms
    White Paper - 15 Oct 2024
    Learn how to identify protein aggregation mechanisms from combined monomer depletion and continuous scattering.
  • Vabysmo
    Drug - 8 Oct 2024
    Consumer Medicine Information (CMI) about Vabysmo intended for persons living in Australia.
  • How biospecimens are advancing the development of weight loss drugs
    White Paper - 3 Oct 2024
    Explore how pharmaceutical researchers are fueling weight loss drug development using biospecimens to unlock the underlying mechanisms of obesity.
  • Metoprolol IV Viatris
    Drug - 25 Sep 2024
    Consumer Medicine Information (CMI) about Metoprolol IV Viatris intended for persons living in Australia.
  • The role of Ki67 block staining in ADC development
    White Paper - 19 Sep 2024
    This article explores the importance of Ki67 block staining for the development of ADCs.
  • DBL Diazepam
    Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about DBL Diazepam intended for persons living in Australia.
  • Tacidine
    Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Tacidine intended for persons living in Australia.
  • Betaloc Injection
    Drug - 29 Aug 2024
    Consumer Medicine Information (CMI) about Betaloc Injection intended for persons living in Australia.
  • Femara
    Drug - 19 Aug 2024
    Consumer Medicine Information (CMI) about Femara intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback